Physician profile
Uta Guo
NPI 1225564172
$4,054.12
in general payments reported to CMS, 2019-2025
21 companies · $614 in 2025
The $614 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,098 · 2022: $235 · 2023: $2,084 · 2024: $23.10 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,038 · Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,038.47 |
| Food and Beverage | $682.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,038.47 | 2023 | |
| Janssen Pharmaceuticals, INC | $499.99 | 2021 | |
| Nuwellis, INC. | $307.86 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $194.21 | 2021-2022 | |
| Medtronic, INC. | $166.39 | 2021 | |
| Abiomed | $140.54 | 2022 | |
| Glaxosmithkline, LLC. | $92.33 | 2021-2024 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $74.89 | 2025 | Gardasil 9, Capvaxive |
| Lilly USA, LLC | $74.73 | 2025 | Jardiance, Zepbound, Mounjaro |
| Neurocrine Biosciences, INC. | $61.77 | 2025 | |
| Novo Nordisk INC | $59.79 | 2025 | Ozempic, Wegovy |
| Dexcom, INC. | $55.51 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.37 | 2025 | Jardiance |
| Insulet Corporation | $44.00 | 2025 | Omnipod |
| Pfizer INC. | $40.54 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $39.63 | 2025 | Airsupra, Farxiga |
| Abbvie INC. | $32.47 | 2025 | |
| Alk-Abello, INC | $26.41 | 2025 | Neffy |
| Avadel Cns Pharmaceuticals, LLC | $24.65 | 2025 | Lumryz |
| Hologic Sales and Service, LLC | $18.15 | 2025 | Aptima |
| Exact Sciences Corporation | $14.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uta Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.